Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Recall Of Valiant Navion Could Cost Medtronic $40M

Executive Summary

The company ordered the recall after three stent fractures and a death occurred in an 89-participant clinical trial.

You may also be interested in...



Results Recap: Medtronic's Valiant Navion Earns FDA Approval Based On 30-Day Results

Results Recap is Medtech Insight's exclusive summary of clinical trial results that have been announced or published in the past week, based on information collected by Meddevicetracker. This week's edition covers the week of Oct. 19 - Oct. 25, including trial announcements from Medtronic, iCAD, PharmaEngine, Inc., Nanobiotix SA, and Myriad Genetics.

Pulse Oximeters May Be Less Accurate For Dark-Skinned People, FDA Warns

The US agency’s safety alert says the devices, which measure blood oxygen levels, may be less accurate in patients with darker skin tones.

US FDA Eyes March For Submission Tracker Pilot Launch

The program will be open to roughly a hundred device firms with traditional 510(k)s under review between March and May of this year.

Topics

Related Companies

UsernamePublicRestriction

Register

LL1132098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel